Infliximab effective in steroid-dependent juvenile eosinophilic fasciitis

Rheumatology

Volumn 47, Issue 6, 2008, Pages 930-932

  Tzaribachev, N ^a   Holzer, U ^a   Schedel, J ^b   Maier, V ^a   Klein, R ^a   Kuemmerle deschner, J ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

BIOPSY TECHNIQUE; CASE REPORT; CHILD CARE; CLINICAL FEATURE; CUSHING SYNDROME; EOSINOPHILIA; EOSINOPHILIC FASCIITIS; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; JOINT LIMITATION; LABORATORY TEST; LETTER; LEUKOCYTOSIS; MALE; MOTOR DYSFUNCTION; PAIN; PRIORITY JOURNAL; RANGE OF MOTION; SCHOOL CHILD; SKIN FIBROSIS; SKIN HYPERTROPHY;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; CHILD; EOSINOPHILIA; FASCIITIS; HUMANS; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44849117821     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken142     Document Type: Letter

References (10)

1. Grisanti MW, Moore TL, Osborn TG, Haber PL. Eosinophilic fasciitis in children. Semin Arthritis Rheum 1089;19:151-7.
2. Williams HJ, Ziter FA, Banta CA. Childhood eosinophilic fasciitis - progression to linear scleroderma. J Rheumatol 1986;13:961-2.
3. Britt WJ, Duray PH, Dahl MV, Goltz RW. Diffuse fasciitis with eosinophilia: A steroid-responsive variant of scleroderma. J Pediatr 1980;97:432-4.
4. Silverman ED, Adornato BT, Miller JJ. Eosinophilic fasciitis in a two-year-old child. Arthritis Rheum 1985;28:948-51.
5. Sibrack LA, Mazur EM, Hoffmann R, Bollet AJ. Eosinophilic fasciitis. Clin Rheum Dis 1982;812:443-54.
6. Pope JE. Scleroderma overlap syndromes. Curr Opin Rheumatol 2002;14:704-10.
7. Farrington ML, Haas JE, Nazar-Stewart V, Mellins ED. Eosinophilic fasciitis in children frequently progresses to scleroderma-like cutaneous fibrosis. J Rheumatol 1993;20:128-32.
8. Alexis AF, Strober BE. Off-label dermatologic uses of anti-TNF-a therapies. J Cutan Med Surg 2005;9:296-302.
9. Drousou A, Kirsner RS, Welsh E et al. Use of infliximab, an antitumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 2003;7:382-6.
10. Lakhampal S, Ginsburg WW, Michet JJ, Doyle JA, Breanndan Morre S. Eosinophilic fasciitis: Clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988;17:221-31.